Opna Bio

Epalinges, Switzerland

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

$38.0M raised

Nov 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Opna Bio raised?

Opna Bio has raised $38.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.

Who are Opna Bio's investors?

Opna Bio's investors include Menlo Ventures, Longitude Capital, Northpond Ventures.

Where is Opna Bio headquartered?

Opna Bio is headquartered in Epalinges, Switzerland.

What does Opna Bio do?

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

What stage is Opna Bio at?

Opna Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 21, 2022.

MLA

"Opna Bio — Funding & Investors." VCBacked, November 21, 2022, https://www.vcbacked.co/company/opna-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Opna Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/opna-bio

Wikipedia (cite web)

{{cite web |title=Opna Bio — Funding & Investors |url=https://www.vcbacked.co/company/opna-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 21, 2022.